Über diesen Podcast

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

461 Folgen · science

BiotechTV - News

Von BiotechTV

In Spotify hörenFunktioniert auch im Browser

Apple PodcastsÖffnen
YouTubeÖffnen
Pocket CastsÖffnen
Amazon MusicÖffnen
DeezerÖffnen

5 weitere Apps

OvercastÖffnen
Player FMÖffnen
CastroÖffnen
Podcast AddictÖffnen
RSSÖffnen

Neueste FolgeUC Berkeley's Gokul Upadhyayula and Eric Betzig are building AI to interpret detailed movies of living cells captured by their MOSAIC microscope8. Sept.21 Min.

Über diesen Podcast

This is the primary news channel of BiotechTV where you will find on the ground reporting by our journalists from biotech hubs throughout the world.

Neue Folgen

Bay Area based Moonwalk Biosciences announced a $70M series B today to advance its adipose-targeted RNAi therapies for obesity and cardiometabolic diseases8. Sept. · 11 Min.
Cloverleaf Bio, a spinout out of Yale, announced $33M in seed financing today that will help it advance its work on a tRNA platform in oncology8. Sept. · 4 Min.
Pareto Securities Healthcare Conference: Sedana Medical's inhaled sedative drug/device combo is currently in front of FDA - they hope to change the ICU with it2. Sept. · 8 Min.
Pareto Securities Healthcare Conference: Pareto's Dan Akschuti highlights the innovation coming out of the Nordics region and companies that have filings in front of FDA2. Sept. · 5 Min.
Congressman Jake Auchincloss discusses the economic impact of biotech, global competition, and efforts he is taking to solidify funding, modernize regulation, and keep the United States on top2. Sept. · 34 Min.
Pareto Securities Healthcare Conference: BioInvent believes that it has found the next big checkpoint in TNFR2 - this summer they had data both in solid and liquid tumors2. Sept. · 8 Min.
Pareto Securities Healthcare Conference: Orexo believes that nasal delivery is superior to other modalities for most uses - they plan to file their naloxone program with FDA immanently2. Sept. · 12 Min.
Pareto Securities Healthcare Conference: Hansa Biopharma has a December 19 PDUFA date with FDA for its IgG depleting therapy that hopes to make more patients eligible for kidney transplant2. Sept. · 11 Min.
Pareto Securities Healthcare Conference: Mendus' cellular immunotherapy has been making progress in numerous cancers - being thoughtful about the setting and goal of treatment have been keys2. Sept. · 8 Min.
A focus on cutting edge science and a busy year of presentations and partnerships has made Circio not just one of the fastest growing biotech companies in the Nordic region, but in all of Europe1. Sept. · 13 Min.